Davunetide PSP Reanalysis Found Sex-Specific Signals in Women
TL;DR: A 2026 post-hoc reanalysis in Molecular Psychiatry found that women assigned davunetide in a prior 52-week progressive supranuclear palsy trial had more favorable scores on the 10-item PSP Rating Scale (PSPRS-10), daily-living measures, and several cogn…
Read article